Editorial: Treatment of comorbidities of asthma and its safety

Overview of attention for article published in Frontiers in Drug Safety and Regulation, February 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 16 X posts from 10 X users, with an upper bound of 15,615 followers.

RT @ACorlateanu: Our new editorial on @FrontiersIn @FrontPharmacol research topic Treatment of #Comorbidities of #Asthma and Its #Safety ht…

RT @ACorlateanu: Our new editorial on @FrontiersIn @FrontPharmacol research topic Treatment of #Comorbidities of #Asthma and Its #Safety ht…

RT @ACorlateanu: Our new editorial on @FrontiersIn @FrontPharmacol research topic Treatment of #Comorbidities of #Asthma and Its #Safety ht…

RT @ACorlateanu: Our new editorial on @FrontiersIn @FrontPharmacol research topic Treatment of #Comorbidities of #Asthma and Its #Safety ht…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.